Johnson & Johnson on Tuesday announced that it would stop selling its talc-based Johnson's Baby Powder in the United States and Canada, making the decision after a consumer products "portfolio reassessment related to Covid-19."
The US healthcare conglomerate said it would wind down sales of the product, which makes up about 0.5 per cent of its US consumer health business, in the coming months, but that retailers will continue to sell existing inventory, the Reuters reported.
J&J faces more than 16,000 lawsuits from consumers claiming its talc products, including Johnson's Baby Powder, caused their cancer. The majority are pending before